Date of Publication: 20-May-2026
INTELLIGENCE OVERVIEW
Agency: USFDA
The FDA has released the ICH M11 Clinical Electronic Structured Harmonized Protocol (CeSHarP) Guidance for Industry, introducing a standardized approach for structuring and electronically exchanging clinical trial protocol information. The guidance aims to improve consistency, efficiency, and interoperability across global clinical research activities.
Clinical trial protocols play a central role in defining study objectives, design, procedures, and analysis plans. However, variability in protocol formats among sponsors has historically created challenges in protocol review and execution. The M11 CeSHarP guidance addresses this by providing a harmonized template and technical specification for standardized protocol content and electronic exchange.
The framework is intended for interventional clinical trials across all phases and therapeutic areas and supports multiple stakeholders, including sponsors, investigators, ethics committees, and regulators. It also promotes content reuse, trial transparency, and streamlined regulatory review processes.
The adoption of M11 CeSHarP represents another step toward greater global harmonization in clinical trial documentation and digital transformation within drug development.
KEYWORDS: Clinical Trial Data Standards, Electronic Clinical Protocols, Protocol Electronic Exchange
REFERENCES: https://www.fda.gov/media/164112/download https://www.fda.gov/regulatory-information/search-fda-guidance-documents/m11-clinical-electronic-structured-harmonised-protocol